This seems to reflect not only interactions of FGFR2‐triggered signalling separately with ER or PR, but also an impact of FGFR2 on the ER‐PR crosstalk, hence the dependence of the functional outcome of its activity on the hormonal milieu of the tumour. Here, PGR is linked to neoplasm.